LifeMD, Inc.
LifeMD, Inc. LFMD Peers
See (LFMD) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LFMD | $13.07 | -4.04% | 596.7M | -39.79 | -$0.33 | N/A |
| ONC | $243.67 | +0.66% | 24.4B | -67.54 | -$3.63 | N/A |
| INSM | $97.15 | -3.47% | 18.5B | -16.43 | -$5.94 | N/A |
| WBA | $11.48 | +0.03% | 9.9B | -1.58 | -$7.29 | +4.36% |
| HROWL | $25.50 | -0.08% | 1.2B | N/A | N/A | N/A |
| HROWM | $26.44 | +0.42% | 1.1B | N/A | N/A | +11.20% |
| LFMDP | $24.25 | +0.17% | 1.1B | -10.75 | -$2.26 | N/A |
| HITI | $2.32 | +1.07% | 186.4M | -25.56 | -$0.09 | N/A |
| PETS | $3.28 | -1.20% | 67.5M | 327.00 | $0.01 | N/A |
| YI | $7.09 | -0.78% | 61.6M | -3.27 | -$2.17 | N/A |
Stock Comparison
LFMD vs ONC Comparison
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 596.7M. In comparison, ONC has a market cap of 24.4B. Regarding current trading prices, LFMD is priced at $13.07, while ONC trades at $243.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -39.79, whereas ONC's P/E ratio is -67.54. In terms of profitability, LFMD's ROE is +2.33%, compared to ONC's ROE of -0.12%. Regarding short-term risk, LFMD is less volatile compared to ONC. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.
LFMD vs INSM Comparison
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 596.7M. In comparison, INSM has a market cap of 18.5B. Regarding current trading prices, LFMD is priced at $13.07, while INSM trades at $97.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -39.79, whereas INSM's P/E ratio is -16.43. In terms of profitability, LFMD's ROE is +2.33%, compared to INSM's ROE of -4.47%. Regarding short-term risk, LFMD is more volatile compared to INSM. This indicates potentially higher risk in terms of short-term price fluctuations for LFMD.
LFMD vs WBA Comparison
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 596.7M. In comparison, WBA has a market cap of 9.9B. Regarding current trading prices, LFMD is priced at $13.07, while WBA trades at $11.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -39.79, whereas WBA's P/E ratio is -1.58. In terms of profitability, LFMD's ROE is +2.33%, compared to WBA's ROE of -0.70%. Regarding short-term risk, LFMD is more volatile compared to WBA. This indicates potentially higher risk in terms of short-term price fluctuations for LFMD.
LFMD vs HROWL Comparison
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 596.7M. In comparison, HROWL has a market cap of 1.2B. Regarding current trading prices, LFMD is priced at $13.07, while HROWL trades at $25.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -39.79, whereas HROWL's P/E ratio is N/A. In terms of profitability, LFMD's ROE is +2.33%, compared to HROWL's ROE of -0.36%. Regarding short-term risk, LFMD is more volatile compared to HROWL. This indicates potentially higher risk in terms of short-term price fluctuations for LFMD.
LFMD vs HROWM Comparison
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 596.7M. In comparison, HROWM has a market cap of 1.1B. Regarding current trading prices, LFMD is priced at $13.07, while HROWM trades at $26.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -39.79, whereas HROWM's P/E ratio is N/A. In terms of profitability, LFMD's ROE is +2.33%, compared to HROWM's ROE of -0.28%. Regarding short-term risk, LFMD is more volatile compared to HROWM. This indicates potentially higher risk in terms of short-term price fluctuations for LFMD.
LFMD vs LFMDP Comparison
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 596.7M. In comparison, LFMDP has a market cap of 1.1B. Regarding current trading prices, LFMD is priced at $13.07, while LFMDP trades at $24.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -39.79, whereas LFMDP's P/E ratio is -10.75. In terms of profitability, LFMD's ROE is +2.33%, compared to LFMDP's ROE of +2.33%. Regarding short-term risk, LFMD is more volatile compared to LFMDP. This indicates potentially higher risk in terms of short-term price fluctuations for LFMD.
LFMD vs HITI Comparison
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 596.7M. In comparison, HITI has a market cap of 186.4M. Regarding current trading prices, LFMD is priced at $13.07, while HITI trades at $2.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -39.79, whereas HITI's P/E ratio is -25.56. In terms of profitability, LFMD's ROE is +2.33%, compared to HITI's ROE of -0.05%. Regarding short-term risk, LFMD is less volatile compared to HITI. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.
LFMD vs PETS Comparison
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 596.7M. In comparison, PETS has a market cap of 67.5M. Regarding current trading prices, LFMD is priced at $13.07, while PETS trades at $3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -39.79, whereas PETS's P/E ratio is 327.00. In terms of profitability, LFMD's ROE is +2.33%, compared to PETS's ROE of +0.00%. Regarding short-term risk, LFMD is less volatile compared to PETS. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.
LFMD vs YI Comparison
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 596.7M. In comparison, YI has a market cap of 61.6M. Regarding current trading prices, LFMD is priced at $13.07, while YI trades at $7.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -39.79, whereas YI's P/E ratio is -3.27. In terms of profitability, LFMD's ROE is +2.33%, compared to YI's ROE of +0.11%. Regarding short-term risk, LFMD is more volatile compared to YI. This indicates potentially higher risk in terms of short-term price fluctuations for LFMD.
LFMD vs RAD Comparison
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 596.7M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, LFMD is priced at $13.07, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -39.79, whereas RAD's P/E ratio is -0.05. In terms of profitability, LFMD's ROE is +2.33%, compared to RAD's ROE of +2.76%. Regarding short-term risk, LFMD is less volatile compared to RAD. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.
LFMD vs RNTX Comparison
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 596.7M. In comparison, RNTX has a market cap of 32.1M. Regarding current trading prices, LFMD is priced at $13.07, while RNTX trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -39.79, whereas RNTX's P/E ratio is -0.50. In terms of profitability, LFMD's ROE is +2.33%, compared to RNTX's ROE of -0.80%. Regarding short-term risk, LFMD is less volatile compared to RNTX. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.
LFMD vs MEDS Comparison
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 596.7M. In comparison, MEDS has a market cap of 13.3M. Regarding current trading prices, LFMD is priced at $13.07, while MEDS trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -39.79, whereas MEDS's P/E ratio is -0.31. In terms of profitability, LFMD's ROE is +2.33%, compared to MEDS's ROE of +0.22%. Regarding short-term risk, LFMD is less volatile compared to MEDS. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.
LFMD vs NEUP Comparison
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 596.7M. In comparison, NEUP has a market cap of 13.2M. Regarding current trading prices, LFMD is priced at $13.07, while NEUP trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -39.79, whereas NEUP's P/E ratio is 0.37. In terms of profitability, LFMD's ROE is +2.33%, compared to NEUP's ROE of +0.31%. Regarding short-term risk, LFMD is less volatile compared to NEUP. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.
LFMD vs CJJD Comparison
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 596.7M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, LFMD is priced at $13.07, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -39.79, whereas CJJD's P/E ratio is -0.46. In terms of profitability, LFMD's ROE is +2.33%, compared to CJJD's ROE of -0.30%. Regarding short-term risk, LFMD is less volatile compared to CJJD. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.
LFMD vs SSY Comparison
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 596.7M. In comparison, SSY has a market cap of 6.7M. Regarding current trading prices, LFMD is priced at $13.07, while SSY trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -39.79, whereas SSY's P/E ratio is -2.43. In terms of profitability, LFMD's ROE is +2.33%, compared to SSY's ROE of +0.12%. Regarding short-term risk, LFMD is less volatile compared to SSY. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.
LFMD vs ATNFW Comparison
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 596.7M. In comparison, ATNFW has a market cap of 4.9M. Regarding current trading prices, LFMD is priced at $13.07, while ATNFW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -39.79, whereas ATNFW's P/E ratio is N/A. In terms of profitability, LFMD's ROE is +2.33%, compared to ATNFW's ROE of -1.47%. Regarding short-term risk, LFMD is more volatile compared to ATNFW. This indicates potentially higher risk in terms of short-term price fluctuations for LFMD.
LFMD vs MDVL Comparison
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 596.7M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, LFMD is priced at $13.07, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -39.79, whereas MDVL's P/E ratio is -0.05. In terms of profitability, LFMD's ROE is +2.33%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, LFMD is less volatile compared to MDVL. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.
LFMD vs LFLYW Comparison
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 596.7M. In comparison, LFLYW has a market cap of 1.4M. Regarding current trading prices, LFMD is priced at $13.07, while LFLYW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -39.79, whereas LFLYW's P/E ratio is -0.18. In terms of profitability, LFMD's ROE is +2.33%, compared to LFLYW's ROE of +0.34%. Regarding short-term risk, LFMD is less volatile compared to LFLYW. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.
LFMD vs LFLY Comparison
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 596.7M. In comparison, LFLY has a market cap of 674.5K. Regarding current trading prices, LFMD is priced at $13.07, while LFLY trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -39.79, whereas LFLY's P/E ratio is -0.12. In terms of profitability, LFMD's ROE is +2.33%, compared to LFLY's ROE of +0.34%. Regarding short-term risk, LFMD is less volatile compared to LFLY. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.
LFMD vs BIMI Comparison
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 596.7M. In comparison, BIMI has a market cap of 1.4K. Regarding current trading prices, LFMD is priced at $13.07, while BIMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -39.79, whereas BIMI's P/E ratio is N/A. In terms of profitability, LFMD's ROE is +2.33%, compared to BIMI's ROE of -2.93%. Regarding short-term risk, LFMD is more volatile compared to BIMI. This indicates potentially higher risk in terms of short-term price fluctuations for LFMD.